An underground market for unapproved slimming drugs is propelled by social media fitness personalities and sellers on communication apps, according to new investigations.
Experimental Treatment Acquiring Popularity Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are urged to contact these accounts directly for supplier links, while also receiving promotional offers.
Thriving Trade on Social Networks
Separately, a robust market exists on messaging services, where communities with numerous of members share comparison photos, injection guides and assertions of rapid British shipping. Sellers market the drug there before redirecting buyers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Preliminary studies suggest it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed digitally as the next Ozempic.
Medical Experts Voice Concerns
However, physicians and pharmacists have cautions that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in users administering substances of unknown origin.
Some experts said the demand for the experimental drug could be connected to the rising price of approved slimming products such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or Telegram is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the British medical regulations.
Some influencers try to sidestep the rules by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer regulations, risking fines, prosecution or imprisonment.
Service Response and Content Elimination
Based on TikTok, the service has taken down violative material and banned associated keywords and query recommendations. The company stated it was committed to keeping the platform safe and allocating resources in strengthening enforcement strategies.
Online Trading Operations
Investigations also found groups with up to nine thousand participants marketing retatrutide using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately displays channels with thousands of users, filled with images of slimming results, glowing testimonials and detailed instructions for preparing or injecting at residence.
Within minutes of entering one group, a seller posted WhatsApp details, where most purchases take place. The vendor provided an instruction manual and promised delivery within two days. When asked whether the product was authentic, one seller said: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about body mass, medical conditions or past usage.
Item Information and Pricing
Inside these communities, messages display black plastic packages with postal service stickers, claiming to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled pens typically sold at £160 for 20 milligrams. When asked how much time a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Oversight and Safety Actions
A spokesperson for the messaging service said it regularly monitored dangerous material on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Healthcare Expert Warnings
“Individuals are injecting substances they cannot confirm. Although the research behind retatrutide is sound, these digital products may not include what they advertise,” said Jason Murphy, the head of pharmacy at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices rising, individuals are turning to online platforms. But fake treatments are highly dangerous. You can’t be certain what’s contained or whether the environment they were produced in was clean,” she said.
Her staff has previously seen individuals injured by personal administration from unverified sources. “We recognize the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be impure or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this point no one can sell [it] for human use,” they explained, noting that any item “falsely representing itself as a Lilly experimental substance not yet approved … may subject users to potentially significant health risks”.
